Founders Investment Banking is pleased to announce that a prominent 340B program management organization has purchased substantially all of the stock of a URAC accredited specialty pharmacy focused on providing care to patients with chronic or difficult to treat conditions across a wide spectrum of therapies. The Company fills prescriptions nationwide, and had experienced average…